Biotech Values

[dewophile]

I can't if you include the following as obvious:

1. dilution is based on # shares issued, which is less than what many expected

2. the fact that less $ was raised now might speak to additional expected revenue from alternative sources (i.e. partnership(s)) in the near future

the strike price is really less relevant imo - if it is at some small discount does that really matter?